Cardiac Refractoriness

Definition

Refractoriness is the property of cardiac tissue that, for a period after each excitation, prevents or impairs re-excitation. Two measures are used. The effective refractory period (ERP) is the longest coupling interval at which a stimulus fails to produce a propagated response; the relative refractory period (RRP) is the longest interval at which a stimulus produces a propagated response but with conduction delay. Both are cycle-length dependent — they shorten as the basic cycle length shortens — and this dependence is the basis of the extrastimulus technique used to measure them.

The reason refractoriness matters beyond the basic-science level is that dispersion of refractoriness is a substrate for reentry, and because refractoriness differentials between adjacent tissues are now exploited clinically to diagnose what a pacing lead has captured. (sources/denker-hps-refractoriness-circ-1983, rating: high)

Key Concepts

Steady State: Parallel Behaviour

Under constant basic cycle length, the His-Purkinje system (HPS) and ventricular muscle behave in parallel: refractoriness of both shortens as the basic cycle length abbreviates. This was the received model, established in studies generally performed during steady-state conditions. Denker et al. confirmed in all 30 of their patients that "the expected abbreviation of refractoriness of the HPS and of ventricular muscle consistently occurred with shortening of constant cycle length" — establishing the conventional behaviour in their cohort before testing what happens when cycle length changes abruptly. (sources/denker-hps-refractoriness-circ-1983, rating: high)

The Divergence With Abrupt Cycle-Length Change

The central finding of the primary source for this concept: when cycle length changes abruptly rather than in steady state, the two tissues diverge. Ventricular muscle responds to the cumulative effect of preceding cycle lengths and varies directly with the preceding cycle length (CLp); the HPS varies inversely with CLp and appears to respond to the direction and rate of change. (sources/denker-hps-refractoriness-circ-1983, rating: high)

The design is what makes the claim clean: the cycle length immediately before the extrastimulus (CLR) was held identical between protocols, so only the cycle length preceding CLR was altered.

• The inverse relationship is the memorable part. HPS refractoriness was 50 ms longer in method IIB than IIA while CLp was 600 ms shorter (patient 9). Across the 11 patients with both protocols, a mean CLp shorter by more than 350 ms produced an RRP 29 ± 7 ms longer (10 of 11 patients)
• Ventricular muscle never contradicted the direct relationship. In method IIA a decrease in ventricular-muscle ERP "was never observed"; in method IIB an increase "was never observed". Across all 11 patients with both protocols, ventricular-muscle ERP was shorter by 18 ± 6 ms in IIB than IIA — without exception
• Three components, as the authors enumerate them: (1) HPS varies inversely with CLp, ventricular muscle directly; (2) HPS refractoriness departs from its own steady-state value for the altered cycle length, whereas ventricular muscle reflects the cumulative steady-state values of CLp and CLR; (3) HPS change is direction-dependent — greater where CLp < CLR — whereas ventricular-muscle change is of similar magnitude in both directions
• The statistical result for the divergence itself: p < .005. The divergence had "not been previously demonstrated in man"
• A useful negative control: in the 16 patients with right bundle branch recordings, no shift in the retrograde activation sequence of His bundle and right bundle occurred between methods, ruling out a route change as the explanation

The Mechanism Is Not Established

This is the most important qualification, and it is easy to lose when the finding is summarised. The authors state plainly: "an exact mechanism for this divergence in behavior cannot be derived from our study". (sources/denker-hps-refractoriness-circ-1983, rating: high)

• The rate-of-change formulation is a consistency argument, not a demonstration. With CLR 600 ms, a CLp of 800 ms gives a rate of change of 200/800 = 25% and a CLp of 400 ms gives 200/400 = 50% — and the authors note these theoretical responses are "quantitively comparable" to the observed magnitudes. They also concede their explanations "may be an oversimplification of complex phenomena"
• A confound they could not measure may underlie the measurement. The measured S2H2 interval is a composite of transseptal, intramuscle, Purkinje-muscle junction (PMJ) and HPS conduction. PMJ refractoriness "cannot be directly assessed" and "could have significantly contributed" — potentially "partially or completely nullified the prolongation of refractoriness of the HPS in some patients". So the measured quantity "may therefore not necessarily parallel the RRP of the HPS as defined here"
• The HPS measure is a conduction measure, not an excitability measure. In this study HPS refractoriness was defined as the onset of conduction delay (RRP) and conduction block (ERP) below the His recording site, during ventricular stimulation. That definitional choice is central to the contradiction below

Application: Diagnosing Capture in Conduction System Pacing

The refractoriness differential between the conduction system and adjacent myocardium is the basis of programmed deep septal stimulation, a maneuver for confirming whether a deep septal lead has captured the left bundle branch — necessary because LBB capture is almost always accompanied by simultaneous local myocardial capture, producing a fused nonselective QRS that obscures the diagnosis. (sources/programmed-septal-stim-lbbp-jce-2020, rating: medium) (sources/denker-pes-lbbap-jce-2020, rating: low)

• The measured differential at a conventional 600 ms drive train is small:

That 55 ms separation underpinned a maneuver diagnostic in 79.7% of cases but nondiagnostic in 20.3% — with no gold standard to adjudicate the failures (sources/programmed-septal-stim-lbbp-jce-2020, rating: medium)

• The differential is protocol-dependent, not a fixed tissue property — which is where the divergence concept becomes clinically useful. Using Denker protocols (short-long-short / long-short-short sequences) in a single case, the LBB-versus-myocardium gap was driven from 55 ms to 150 ms (myocardium 250 ms vs LBB 400 ms) and then reversed in sign (LBB 250 ms vs myocardium 290 ms), producing opposite capture diagnoses at an identical pacing output, lead position and 280 ms coupling interval (sources/denker-pes-lbbap-jce-2020, rating: low)
• Why the direction matters clinically: a short-long sequence prolongs the LBB ERP (yielding myocardial-only capture at the extrastimulus), while a long-short sequence prolongs myocardial ERP and shortens LBB ERP (yielding selective LBB capture). This is the same directional dependence Denker described for the HPS — short-to-long changes having the greater effect
• The failure modes are refractoriness failure modes: an ERP gap <30 ms makes the response uninterpretable and can produce a false positive (because encroaching on the myocardium's relative refractory period delays myocardial conduction independently of capture), and intra-LBB conduction delay can shift the QRS to myocardial morphology despite LBB capture, causing the LBB ERP to be underestimated

Contradictions / Open Questions

• The divergence is contradicted by the canine literature, and the reconciliation is untested. Han and Moe (Am J Physiol 1969;217:106), studying canine hearts, found the HPS and ventricular muscle to behave in parallel fashion, with both tissues showing a cumulative effect of preceding cycle lengths — and specifically, an increase in HPS refractoriness after abrupt short-to-long change "was not suggested by animal studies". Denker et al. attribute the discrepancy to methodology: Han and Moe stimulated the His bundle directly and defined His refractoriness as the minimal interval producing a propagated response (i.e. excitability), whereas Denker defined HPS refractoriness as conduction delay and block of a propagated impulse during ventricular stimulation. They add species differences as a second possibility. This is plausible but untested, and it cuts both ways: if the divergence arises from how HPS refractoriness is defined rather than from a fundamental tissue difference, the "dissociation" may be partly a measurement construct. No study in this wiki measures both properties in the same preparation to settle it. (sources/denker-hps-refractoriness-circ-1983, rating: high)
• The mechanism is unknown, and the wiki should not present it as known. Denker demonstrated a phenomenon with a direction and a magnitude; the authors explicitly could not derive an explanation, offered the rate-of-change account as a consistency argument, and identified an unmeasurable Purkinje-muscle junction confound that could account for part of the observed behaviour. The LBBAP sources describe this as "Denker's dissociation" and use it as a mechanistic basis, which is fair as a description of behaviour but overstates it as a mechanism. (sources/denker-hps-refractoriness-circ-1983, rating: high) (sources/denker-pes-lbbap-jce-2020, rating: low)
• The population in which the divergence was shown is not the population in which it is used. Denker studied patients with normal intraventricular conduction, normal HV intervals (30–55 ms), and excluded preexisting bundle branch block. The LBBAP capture-confirmation protocols are applied precisely in patients with conduction disease — LBBB and RBBB are common in those cohorts. The divergence has never been demonstrated in the substrate where it is clinically invoked. (sources/denker-hps-refractoriness-circ-1983, rating: high) (sources/programmed-septal-stim-lbbp-jce-2020, rating: medium)
• The response is a majority phenomenon, not a universal one. Divergence was directionally consistent in most patients but not all: in method IIA, HPS RRP was longer in 2 of 11 and unchanged in 2; in method IIB it was shorter in 4 of 30 and unchanged in 3. Any protocol that assumes a predictable directional response will not be diagnostic in every patient. (sources/denker-hps-refractoriness-circ-1983, rating: high)
• Granularity is poor at the individual level. The RRP changes were small in absolute terms — 350 ± 29 → 344 ± 29 ms is a 6 ms shift against a standard deviation five times larger. The direction is reproducible and significant within patients, but these numbers cannot discriminate the two states in an individual patient, which is what a bedside protocol would need. (sources/denker-hps-refractoriness-circ-1983, rating: high)
• Clinical consequence remains unevaluated — by the primary source's own statement. "The role, if any, that abrupt cycle length changes play in the initiation of clinical arrhythmias needs to be evaluated." The reentry connection is a plausible inference from dispersion of refractoriness, not a demonstrated outcome. (sources/denker-hps-refractoriness-circ-1983, rating: high)
• Does the LBB behave like the HPS? The clinical application substitutes the left bundle branch for the His-Purkinje system, 37 years later, with a different stimulation route (deep septal rather than RV apical) and an antegrade rather than retrograde measurement context. The shared refractoriness behaviour is assumed. The plausibility is supported by the ERP values being in a similar range (myocardium ~223–263 ms, conduction tissue ~318 ms at a 600 ms drive), but the substitution is an extrapolation. (sources/denker-pes-lbbap-jce-2020, rating: low)

Connections

• Related to concepts/Left-Bundle-Branch-Area-Pacing — the clinical protocol that exploits the myocardial-vs-conduction-system refractoriness differential
• Related to concepts/Conduction-System-Pacing — the umbrella category
• Related to concepts/Cardiac-Repolarization — refractoriness and repolarisation are distinct but coupled properties; action potential duration is the cellular correlate of refractoriness, and the canine/porcine work compared action potential duration between HPS and ventricular muscle
• Related to concepts/Wide-Complex-Tachycardia and concepts/Fascicular-Ventricular-Tachycardia — reentry within the HPS is the clinical setting where retrograde HPS refractoriness and conduction delay are directly relevant
• Related to concepts/Antiarrhythmic-Drugs — the authors note that awareness of HPS refractory properties "may be helpful in determining disease states of the HPS or drug effects"

Sources

• sources/denker-hps-refractoriness-circ-1983
• sources/programmed-septal-stim-lbbp-jce-2020
• sources/denker-pes-lbbap-jce-2020